These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38408060)

  • 1. Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems.
    Tsui JI; Rossi SL; Cheng DM; Bendiks S; Vetrova M; Blokhina E; Winter M; Gnatienko N; Backonja M; Bryant K; Krupitsky E; Samet JH
    PLoS One; 2024; 19(2):e0297948. PubMed ID: 38408060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial.
    Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Coleman SM; Doyle MF; Yaroslavtseva T; Bridden C; So-Armah K; Tracy R; Bryant K; Lioznov D; Krupitsky E; Samet JH
    JAMA Netw Open; 2020 May; 3(5):e204330. PubMed ID: 32383748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
    O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
    J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.
    Garbutt JC; Kampov-Polevoy AB; Kalka-Juhl LS; Gallop RJ
    JAMA Psychiatry; 2016 Oct; 73(10):1056-1063. PubMed ID: 27627782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Horne AW; Vincent K; Hewitt CA; Middleton LJ; Koscielniak M; Szubert W; Doust AM; Daniels JP;
    Lancet; 2020 Sep; 396(10255):909-917. PubMed ID: 32979978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in Drinking was Associated With Improved Clinical Outcomes in Women With HIV Infection and Unhealthy Alcohol Use: Results From a Randomized Clinical Trial of Oral Naltrexone Versus Placebo.
    Cook RL; Zhou Z; Miguez MJ; Quiros C; Espinoza L; Lewis JE; Brumback B; Bryant K
    Alcohol Clin Exp Res; 2019 Aug; 43(8):1790-1800. PubMed ID: 31373701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin combined with naltrexone for the treatment of alcohol dependence.
    Anton RF; Myrick H; Wright TM; Latham PK; Baros AM; Waid LR; Randall PK
    Am J Psychiatry; 2011 Jul; 168(7):709-17. PubMed ID: 21454917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot Study of Low-dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-controlled, Crossover Clinical Trial.
    Beaudette-Zlatanova B; Lew RA; Otis JD; Branch-Elliman W; Bacorro E; Dubreuil M; Eyvazzadeh C; Kaur M; Lazzari AA; Libbey C; Monach PA
    Clin Ther; 2023 May; 45(5):468-477. PubMed ID: 37045708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Perioperative Gabapentin Use on Postsurgical Pain in Patients Undergoing Head and Neck Mucosal Surgery: A Randomized Clinical Trial.
    Townsend M; Liou T; Kallogjeri D; Schoer M; Scott-Wittenborn N; Lindburg M; Bottros M; Jackson RS; Nussenbaum B; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):959-966. PubMed ID: 29710075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.
    Collins SE; Duncan MH; Saxon AJ; Taylor EM; Mayberry N; Merrill JO; Hoffmann GE; Clifasefi SL; Ries RK
    Lancet Psychiatry; 2021 Apr; 8(4):287-300. PubMed ID: 33713622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.
    Springer SA; Di Paola A; Azar MM; Barbour R; Krishnan A; Altice FL
    Drug Alcohol Depend; 2017 May; 174():158-170. PubMed ID: 28334661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.
    Krupitsky E; Blokhina E; Zvartau E; Verbitskaya E; Lioznov D; Yaroslavtseva T; Palatkin V; Vetrova M; Bushara N; Burakov A; Masalov D; Mamontova O; Langleben D; Poole S; Gross R; Woody G
    Lancet HIV; 2019 Apr; 6(4):e221-e229. PubMed ID: 30880163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin for the management of chronic pelvic pain in women.
    AbdelHafeez MA; Reda A; Elnaggar A; El-Zeneiny H; Mokhles JM
    Arch Gynecol Obstet; 2019 Nov; 300(5):1271-1277. PubMed ID: 31435774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
    Tindle HA; Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Yaroslavtseva T; Bendiks S; Patts G; Hahn J; So-Armah K; Stein MD; Bryant K; Lioznov D; Krupitsky E; Samet JH
    JAMA Netw Open; 2022 Aug; 5(8):e2225129. PubMed ID: 35930287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
    Wallace MS; Irving G; Cowles VE
    Clin Drug Investig; 2010; 30(11):765-76. PubMed ID: 20818838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen for alcohol use disorder.
    Agabio R; Saulle R; Rösner S; Minozzi S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012557. PubMed ID: 36637087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: Study design challenges and pilot study results.
    Cook RL; Weber KM; Mai D; Thoma K; Hu X; Brumback B; Karki M; Bryant K; Rathore M; Young M; Cohen M
    Contemp Clin Trials; 2017 Sep; 60():72-77. PubMed ID: 28642209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial.
    de Leeuw TG; Mangiarini L; Lundin R; Kaguelidou F; van der Zanden T; Pasqua OD; Tibboel D; Ceci A; de Wildt SN;
    Trials; 2019 Jan; 20(1):49. PubMed ID: 30646965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.